NOTES PREPARED BY THE INDEPENDENT ACCOUNTING FIRM OF L.L.BRADFORD
The Company is engaged in investing in financial instruments and companies worldwide. During May 2012, the Company purchased 100% interest in a European entity for its investing strategies utilizing the EURO currency.
Note 2 – Investment in marketable securities
Investment in marketable securities consists of 2,132,157 shares of common stock in a publically traded company at a cost of $1 million. During the period from January 1, 2012 through September 10, 2012, the Company recorded an unrealized loss of $0.1 million. As of September 17, 2012, the estimated fair value of the shares was $0.9 million.
During August 2012, a Stock Purchase Agreement was entered into to purchase 60% of a Delaware corporation in exchange for $7.5 million in order to effect the purchase of a majority control of the publically traded company noted in the preceding paragraph. As of the date of these financials, the
Note 3 – Commitments and Contingencies
During September 2012, the Company entered into a settlement agreement to satisfy outstanding debt and accrued interest carried on the Company’s financials at approximately $1.0 million. The Company had previously defended against the penalties and interest but agreed to a total settlement of approximately $2.9 million. Accordingly, the Company recorded settlement expense of $1.9 million.
During August 2012, a subsidiary (“Subsidiary”) of the Company entered into an Investors’ General Agreement and Investment Platform Provider Business Agreement (hereafter the “Investor Agreement”). The Investor Agreement describes the profit sharing between the investors and the Subsidiary and provides for weekly payment of those profits. The agreement will be ongoing for five years.
Note 1 – Nature of Business and Summary of Significant Accounting Policies
The Company is engaged in investing in financial instruments and companies worldwide. During May 2012, the Company purchased 100% interest in a European entity for its investing strategies utilizing the EURO currency.
Summary of Significant Accounting Policies Basis of Presentation
These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States. The Company’s fiscal year-end is December 31. The Company’s reporting currency is the United States dollar (USD) and functional currency is the EURO. Foreign currency assets and liabilities are translated into their U.S. dollar equivalents based on year end exchange rates. Revenue and expense accounts are translated at average exchange rates. Aggregate exchange gains and losses arising from the translation of foreign assets and liabilities are included in shareholders' equity as a component of comprehensive income. Accumulated gain on foreign currency translation adjustment was
Cash and Cash Equivalents
Cash equivalents include money market accounts which have maturities of three months or less. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. Cash equivalents are stated at cost plus accrued interest, which approximates market value.
Revenue Recognition
Investments in Financial Instruments – The Company earns commissions based on returns from investments in financial instruments. Revenues are recorded upon receipt of actual returns.
Costs include commissions or revenue sharing arrangements with other parties.
Fair Value of Financial Instruments
The Company’s financial instruments include cash, receivables, available-for-sale securities and due to related parties. Management believes the fair values of these financial instruments approximate their carrying values due to their shortterm nature.
For the period from January 1, 2012, through September 17, 2012, the company reported net income of $88,439,000, or $0.53 per share, on consolidated revenues of $283,952,000.